Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A2 | P43354 | 4/20 | 0.59 |
| ▸ | SOS2 | Q07890 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | FERMT2 | Q96AC1 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CCR1 | P32246 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5765299 | 0.83 | NR4A2 (0.58) | NR4A2SOS2CYP3A4ALDH1A1TSHR | |
| SCHEMBL22323491 | 0.81 | HTT (0.41) | NR4A2SOS2ACHE | |
| SCHEMBL20494859 | 0.81 | NR4A2 (0.56) | NR4A2SOS2CYP3A4ALDH1A1TSHR | |
| SCHEMBL10424586 | 0.81 | NR4A2 (0.56) | NR4A2SOS2CYP3A4ALDH1A1TSHR | |
| SCHEMBL29392254 | 0.81 | NR4A2 (0.56) | NR4A2SOS2CYP3A4ALDH1A1TSHR | |
| SCHEMBL18283403 | 0.80 | ALDH1A1 (0.50) | NR4A2SOS2CYP3A4ALDH1A1ALOX15 | |
| SCHEMBL6473683 | 0.78 | HPGDS (0.44) | CYP3A4ALDH1A1TSHRFERMT2MAPT | |
| SCHEMBL15111074 | 0.77 | NR4A2 (0.46) | NR4A2SOS2CYP3A4ALDH1A1ALOX15 | |
| SCHEMBL2519868 | 0.77 | ALDH1A1 (0.54) | NR4A2SOS2CYP3A4ALDH1A1CYP1A2 | |
| SCHEMBL18283388 | 0.77 | NR4A2 (0.46) | NR4A2SOS2CYP3A4ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3366311-B1 | HYDRAZINO-1H-IMIDAZOQUINOLIN-4-AMINES AND CONJUGATES MADE THEREFROM | 3M INNOVATIVE PROPERTIES CO (US) | 2020-02-26 | — | — | EP | disclosed |
| US-10406142-B2 | Hydrazino 1H-imidazoquinolin-4-amines and conjugates made therefrom | 3M LNNOVATIVE PROPERTIES COMPANY (US) | 2019-09-10 | — | — | US | disclosed |
| EP-3366311-A1 | HYDRAZINO 1H-IMIDAZOQUINOLIN-4-AMINES AND CONJUGATES MADE THEREFROM | 3M Innovative Properties Co. (US) | 2018-08-29 | — | — | EP | disclosed |
| EP-2718292-B1 | HYDRAZINO 1H-IMIDAZOQUINOLIN-4-AMINES AND CONJUGATES MADE THEREFROM | 3M INNOVATIVE PROPERTIES CO (US) | 2018-03-14 | — | — | EP | disclosed |
| US-20170173164-A1 | HYDRAZINO 1H-IMIDAZOQUINOLIN-4-AMINES AND CONJUGATES MADE THEREFROM | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2017-06-22 | — | — | US | disclosed |
| US-9585968-B2 | Hydrazino 1H-imidazoquinolin-4-amines and conjugates made therefrom | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-03-07 | — | — | US | disclosed |
| US-20150352218-A1 | HYDRAZINO 1H-IMIDAZOQUINOLIN-4-AMINES AND CONJUGATES MADE THEREFROM | 3M INNOVATIVE PROPERTIES COMPANY | 2015-12-10 | — | — | US | disclosed |
| US-9107958-B2 | Hydrazino 1H-imidazoquinolin-4-amines and conjugates made therefrom | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-08-18 | — | — | US | disclosed |
| US-20140286988-A1 | HYDRAZINO 1H-IMIDAZOQUINOLIN-4-AMINES AND CONJUGATES MADE THEREFROM | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-09-25 | — | — | US | disclosed |
| EP-2718292-A1 | HYDRAZINO 1H-IMIDAZOQUINOLIN-4-AMINES AND CONJUGATES MADE THEREFROM | 3M Innovative Properties Company (US) | 2014-04-16 | — | — | EP | disclosed |
| EP-1789042-A4 | 1-ALKOXY 1H-IMIDAZO RING SYSTEMS AND METHODS | 3M INNOVATIVE PROPERTIES CO (US) | 2009-07-22 | — | — | EP | disclosed |
| US-20090005376-A1 | imidazonaphthyridines, imidazopyridines, imidazoquinolines, and imidazote-trahydroquinolines; immunomodulators for inducing cytokine biosynthesis; for treatment of viral and neoplastic diseases | 3M INNOVATIVE PROPERTIES COMPANY | 2009-01-01 | — | — | US | disclosed |
| CN-101312975-A | Method for 1h-imidazo[4,5-c]pyridines and analogs thereof | COLEY PHARM GROUP INC (US) | 2008-11-26 | — | — | CN | disclosed |
| EP-1937683-A1 | METHOD FOR 1H-IMIDAZOÝ4,5-c¨PYRIDINES AND ANALOGS THEREOF | Coley Pharmaceutical Group, Inc. (US) | 2008-07-02 | — | — | EP | disclosed |
| US-20070219196-A1 | AMIDE SUBSTITUTED IMIDAZOPYRIDINES, IMIDAZOQUINOLINES, AND IMIDAZONAPHTHYRIDINES | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2007-09-20 | — | — | US | disclosed |
| EP-1789042-A2 | 1-ALKOXY 1H-IMIDAZO RING SYSTEMS AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-05-30 | — | — | EP | disclosed |
| WO-2007035935-A1 | METHOD FOR 1H-IMIDAZO[4,5-c]PYRIDINES AND ANALOGS THEREOF | COLEY PHARMACEUTICAL GROUP, INC. (US) | 2007-03-29 | — | — | WO | disclosed |
| EP-1730143-A2 | AMIDE SUBSTITUTED IMIDAZOPYRIDINES, IMIDAZOQUINOLINES, AND IMIDAZONAPHTHYRIDINES | 3M Innovative Properties Company (US) | 2006-12-13 | — | — | EP | disclosed |
| WO-2006028962-A2 | 1-ALKOXY 1H-IMIDAZO RING SYSTEMS AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2006-03-16 | — | — | WO | disclosed |
| WO-2005094531-A2 | AMIDE SUBSTITUTED IMIDAZOPYRIDINES, IMIDAZOQUINOLINES, AND IMIDAZONAPHTHYRIDINES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-10-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140286988-A1 | HYDRAZINO 1H-IMIDAZOQUINOLIN-4-AMINES AND CONJUGATES MADE THEREFROM | IL15, IL2, HNMT | NR4A2 2816/4885SOS2 4201/4885CYP3A4 1978/4885 |
| US-20170173164-A1 | HYDRAZINO 1H-IMIDAZOQUINOLIN-4-AMINES AND CONJUGATES MADE THEREFROM | IL15, IL2, HNMT | NR4A2 2816/4885SOS2 4201/4885CYP3A4 1978/4885 |
| US-10406142-B2 | Hydrazino 1H-imidazoquinolin-4-amines and conjugates made therefrom | IL15, IL2, HNMT | NR4A2 2816/4885SOS2 4201/4885CYP3A4 1978/4885 |
| US-20070219196-A1 | AMIDE SUBSTITUTED IMIDAZOPYRIDINES, IMIDAZOQUINOLINES, AND IMIDAZONAPHTHYRIDINES | IL2, IL4, IFNG | NR4A2 391/4885SOS2 4475/4885CYP3A4 814/4885 |
| US-20150352218-A1 | HYDRAZINO 1H-IMIDAZOQUINOLIN-4-AMINES AND CONJUGATES MADE THEREFROM | IL15, IL2, HNMT | NR4A2 2816/4885SOS2 4201/4885CYP3A4 1978/4885 |
| US-20090005376-A1 | imidazonaphthyridines, imidazopyridines, imidazoquinolines, and imidazote-trahydroquinolines; immunomodulators for inducing cytokine biosynthesis; for treatment of viral and neoplastic diseases | IL2, IL4, IRF3 | NR4A2 186/4885SOS2 3394/4885CYP3A4 386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.